# Atrial Fibrillation: Risk and Benefits of Anti-coagulation in the Elderly

> **NCT03828162** · — · COMPLETED · sponsor: **Karolinska Institutet** · enrollment: 2943 (actual)

## Conditions studied

- Anticoagulants Causing Adverse Effects in Therapeutic Use
- Atrial Fibrillation
- Frail Elderly Syndrome

## Interventions

- **DRUG:** Anticoagulants

## Key facts

- **NCT ID:** NCT03828162
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11-01
- **Primary completion:** 2017-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 2943 (ACTUAL)
- **Last updated:** 2019-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03828162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03828162, "Atrial Fibrillation: Risk and Benefits of Anti-coagulation in the Elderly". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03828162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*